
The Hidden Cost of Diabetes Tech: Why 'Affordable Access' Is a Trojan Horse for Pharma Profit
The unified call for affordable diabetes technology masks a deeper regulatory battle. Who truly benefits from this 'access' push?

The unified call for affordable diabetes technology masks a deeper regulatory battle. Who truly benefits from this 'access' push?

The bizarre story of 7,000 hacked robot vacuums isn't funny—it's a terrifying blueprint for future cyberattacks on IoT.

VCU Health's move on Hospital-at-Home and RPM governance isn't about patient care; it's a power play defining the future of digital health.

The disappearing Lamborghini mystery isn't about joyriding; it's a chilling indicator of systemic vulnerability in modern automotive tech.

The FBI's search for a lost pacemaker using 'signal sniffer technology' isn't about one missing device; it's a chilling preview of ubiquitous government tracking.

The supposed 'best medical technology stocks' are a classic Wall Street trap. Discover the hidden losers in the 2024 MedTech boom.

The appointment of Alexandra Villoch isn't just a promotion; it's a strategic declaration about the future of large-scale healthcare administration and financial control.

Oura's CEO talks healthcare, but the real story behind wearable technology is data monetization and medical gatekeeping.

NYC Health + Hospitals celebrates a milestone in **robotic-assisted bronchoscopy**. But behind the PR spin lies a critical debate on medical technology adoption and cost.

Forget missiles. Taiwan's true global leverage lies in **semiconductor manufacturing**. This is the real choke point.

Adaptive gaming technology is heralded as a revolution, but we must analyze the true winners and losers in this new era of inclusive digital interaction.

The battle over **digital health** data just got personal. A Swedish government developer is exposing the rot beneath the surface of consumer **mHealth apps**, revealing a crisis of trust in **healthcare technology**.